glp-1 diarrhea mechanism Frontiers Mechanisms of action of GLP-1

Studies indicate that when patients receive timely feedback on their condition and treatment efficacy, they typically exhibit higher compliance and a more positive outlook on their treatment [216,217,218]

These include situations where metformin is ineffective, contraindicated, or when patients fail to reach their target glycemic control despite treatment with metformin and other medications

By targeting the NNMT enzyme, it may help enhance cellular energy, promote fat utilization, and support lean muscle retention

However, it is crucial to understand that microdosing GLP-1 is not an evidence-based practice and lacks formal clinical trial data supporting its efficacy or safety